First HD multifocal lens for presbyopia and astigmatism

Article

opcon has launched the LENTIS Mplustoric intraocular lens (IOL.

Topcon has launched the LENTIS Mplustoric intraocular lens (IOL, designed to provide astigmatic patients the advanced benefits of Topcon's patented high-definition LENTIS Mplus technology. The company will officially present the lens to the market at the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS) meeting in Brighton 11-12 November.

The LENTIS Mplustoric combines Topcon's LENTIS Mplus lens with the toric functionalities of the Tplus series. The LENTIS Mplus, which launched in July 2009, has been fitted in over 3,000 patients across the UK. Clinical trials have shown a reported rate of 95% patient satisfaction. Unlike other multifocal IOLs (MIOLs), it has a unique sector-shaped near-vision segment and uses only one transition zone, allowing, claims Topcon, for seamless transition between the near, intermediate and far vision zones and minimal to no risk of halos and glare in patient vision.

Professor Sunil Shah, Consultant Ophthalmologist at the Midland Eye Institute comments: “The LENTIS Mplustoric is simply the best all-in-one lens solution combining presbyopia correction with astigmatism. It is a major technical step forward for the IOL industry as it is the best combination of two highly advanced technologies. This lens has enabled us to better correct the vision of a wider range of patients and the outcomes have so far been remarkable.”

Gloria McCall, Topcon Surgical adds, “Topcon is excited about the launch of the LENTIS Mplustoric and looks forward to presenting it to the UK's top ophthalmologists at the UKISCRS meeting in November. The new lens offers high-definition glass-free vision to patients who would previously not have been suitable for our leading LENTIS Mplus design.”

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.